Literature DB >> 18644441

Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.

Bernard Van Eerdenbrugh1, Ludo Froyen, Jan Van Humbeeck, Johan A Martens, Patrick Augustijns, Guy Van den Mooter.   

Abstract

d-alpha-Tocopherol polyethylene glycol 1000 succinate (TPGS)-stabilized nanosuspensions (25wt%, relative to the drug weight) were produced by media milling for 9 model drug compounds [cinnarizine, griseofulvin, indomethacin, itraconazole, loviride, mebendazole, naproxen, phenylbutazone and phenytoin]. After 3 months of storage at room temperature, Ostwald ripening occurred in all of the samples, except for indomethacin. Whereas lowering the temperature could slow down the ripening, it markedly increased upon storage at 40 degrees C. As for ripening, settling generally became more pronounced at 40 degrees C compared to 4 degrees C. As the nanosuspensions were afflicted by Ostwald ripening and settling, we explored nanosuspension drying as a strategy to circumvent these stability issues. Spray-drying and freeze-drying were evaluated for nanosuspensions and coarse reference suspensions of the compounds. Nanoparticle agglomeration could be visually observed in all of the powders. To evaluate the effect of agglomeration on the key characteristic of drug nanocrystals (i.e. rapid dissolution), dissolution experiments were performed under poor sink conditions. It was found that the compounds could be categorized into 3 groups: (i) compounds for which it was impossible to differentiate between coarse and nanosized products (griseofulvin, mebendazole, naproxen), (ii) compounds that gave clear differences in dissolution profiles between the nanosized and the coarse products, but for which drying of the nanosuspensions did not decrease the dissolution performance of the product (indomethacin, loviride, phenytoin) and (iii) compounds that showed differences between coarse and nanosized products, but for which drying of the nanosuspensions resulted in a significant decrease of the dissolution rate (cinnarizine, itraconazole, phenylbutazone). To gain insight on the influence of the drug compound characteristics on the dissolution of the dried products, the dissolution behavior of the compounds of the second and the third group was linked to the compound's characteristics. It was found that compounds with a more hydrophobic surface resulted in agglomerates which were harder to disintegrate, for which dissolution was compromised upon drying. The same was found for compounds having higher logP values.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644441     DOI: 10.1016/j.ejps.2008.06.009

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  25 in total

1.  Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs.

Authors:  Toshiyuki Niwa; Satoru Miura; Kazumi Danjo
Journal:  Pharm Res       Date:  2011-05-28       Impact factor: 4.200

2.  Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions.

Authors:  Peng Liu; Odile De Wulf; Johanna Laru; Teemu Heikkilä; Bert van Veen; Juha Kiesvaara; Jouni Hirvonen; Leena Peltonen; Timo Laaksonen
Journal:  AAPS PharmSciTech       Date:  2013-04-25       Impact factor: 3.246

3.  Formulation and stability testing of itraconazole crystalline nanoparticles.

Authors:  Alia A Badawi; Mohamed Ahmed El-Nabarawi; Doaa Ahmed El-Setouhy; Sami Ahmed Alsammit
Journal:  AAPS PharmSciTech       Date:  2011-06-25       Impact factor: 3.246

4.  Formulation and performance of danazol nano-crystalline suspensions and spray dried powders.

Authors:  Sumit Kumar; Rajan Jog; Jie Shen; Banu Zolnik; Nakissa Sadrieh; Diane J Burgess
Journal:  Pharm Res       Date:  2014-11-11       Impact factor: 4.200

Review 5.  Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges.

Authors:  Anagha Bhakay; Mahbubur Rahman; Rajesh N Dave; Ecevit Bilgili
Journal:  Pharmaceutics       Date:  2018-07-08       Impact factor: 6.321

6.  Anti-inflammation effects of Sophora flavescens nanoparticles.

Authors:  Chun-Chao Han; Yingzi Wang
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

7.  Understanding the structure and stability of paclitaxel nanocrystals.

Authors:  Jiexin Deng; Leaf Huang; Feng Liu
Journal:  Int J Pharm       Date:  2010-02-16       Impact factor: 5.875

Review 8.  Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.

Authors:  Lei Gao; Guiyang Liu; Jianli Ma; Xiaoqing Wang; Liang Zhou; Xiang Li; Fang Wang
Journal:  Pharm Res       Date:  2012-10-17       Impact factor: 4.200

9.  Nanocrystals for the parenteral delivery of poorly water-soluble drugs.

Authors:  Bo Sun; Yoon Yeo
Journal:  Curr Opin Solid State Mater Sci       Date:  2012-12-01       Impact factor: 11.354

10.  Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia.

Authors:  Csaba Bartos; Rita Ambrus; Gábor Katona; Tamás Sovány; Róbert Gáspár; Árpád Márki; Eszter Ducza; Anita Ivanov; Ferenc Tömösi; Tamás Janáky; Piroska Szabó-Révész
Journal:  Drug Des Devel Ther       Date:  2019-11-28       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.